Coronavirus Vaccines
Russia accused of spreading false information to sell its vaccine
Sign up now: Get ST's newsletters delivered to your inbox

Shipping containers with 300,000 doses of Russia's Sputnik V vaccine at Ezeiza International Airport in Buenos Aires on Dec 24. The shipment is part of a 10-million-dose deal with Argentina.
PHOTO: AGENCE FRANCE-PRESSE
BRUSSELS • The European Union's top diplomat has said that Russian public media had spread false information on European and American Covid-19 vaccines in countries where it wants to sell its own shot against the coronavirus.
"Western vaccine developers are openly mocked on multilingual Russian state-controlled media, which has in some cases led to absurd claims that vaccines will turn people into monkeys," Mr Josep Borrell said in a blog post.
"Such narratives are apparently directed at countries where Russia wants to sell its own vaccine, Sputnik V," Mr Borrell said, noting that these moves threatened public health amid the pandemic. He gave no specific examples.
Moscow has repeatedly denied these accusations, and alleges that Sputnik V is being targeted by a foreign-backed disinformation campaign.
The Russian Direct Investment Fund, which is responsible for marketing the vaccine abroad, did not respond to a request for comment on Mr Borrell's statement, and Roskomnadzor, the Russian media and communications watchdog, also did not respond.
When drugmaker AstraZeneca, which worked with Oxford University on its vaccine, paused a clinical trial in September due to the then unexplained illness of a volunteer, Kremlin spokesman Dmitry Peskov told reporters that Sputnik V was more reliable because it was based on an adenovirus found in humans, whereas the British candidate was a "monkey vaccine".
Trials of the vaccine, which uses a bioengineered version of a harmless common cold virus found in chimpanzees to instruct human cells to make antigens, were resumed in Britain, within days after getting the green light from safety watchdogs.
Russia last week dispatched its first batch of coronavirus vaccine to Argentina as part of a 10-million-dose deal. It has signed supply deals with a number of other Latin American and Asian countries. The Russian shot costs less than US$20 (S$26.60) per person for the necessary two doses.
REUTERS
